期刊
CHEMBIOCHEM
卷 16, 期 9, 页码 1264-1278出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.201500072
关键词
antivitamins; drugs; enzyme inhibitors; medicinal chemistry; vitamins
资金
- Swiss National Science Foundation [200021-117822]
- Forschungskredit of the University of Zurich UZH
- Institute of Chemistry of the University of Zurich
- Swiss National Science Foundation (SNF) [200021-117822] Funding Source: Swiss National Science Foundation (SNF)
Antivitamins represent a broad class of compounds that counteract the essential effects of vitamins. The symptoms triggered by such antinutritional factors resemble those of vitamin deficiencies, but can be successfully reversed by treating patients with the intact vitamin. Despite being undesirable for healthy organisms, the toxicities of these compounds present considerable interest for biological and medicinal purposes. Indeed, antivitamins played fundamental roles in the development of pioneering antibiotic and antiproliferative drugs, such as prontosil and aminopterin. Their development and optimisation were made possible by the study, throughout the 20th century, of the vitamins' and antivitamins' functions in metabolic processes. However, even with this thorough knowledge, commercialised antivitamin-based drugs are still nowadays limited to antagonists of vitamins B-9 and K. The antivitamin field thus still needs to be explored more intensely, in view of the outstanding therapeutic success exhibited by several antivitamin-based medicines. Here we summarise historical achievements and discuss critically recent developments, opportunities and potential limitations of the antivitamin approach, with a special focus on antivitamins K, B-9 and B-12.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据